- Delivers First Quarter Revenue of
$345.3 Million; GAAP Diluted Earnings Per Share (EPS) of
$0.70
- First Quarter Non-GAAP Adjusted
Diluted EPS of $1.06, In-Line with Company Expectations
- Company Continues to Expect Fiscal
Year 2016 GAAP Diluted EPS in a Range of $4.33 to $4.73 and Fiscal
Year 2016 Non-GAAP Adjusted Diluted EPS in a Range of $5.40 to
$5.85
Helen of Troy Limited (NASDAQ, NM:HELE), designer, developer and
worldwide marketer of consumer brand-name housewares,
healthcare/home environment, nutritional supplement and beauty
products, today reported results for the three-month period ended
May 31, 2015.
Julien R. Mininberg, Chief Executive Officer, stated: “We had a
solid first quarter positioning us well to achieve our annual
goals. The quarter was highlighted by a double digit increase in
revenue and growth in adjusted diluted earnings per share, in line
with our expectations, despite a greater-than-expected impact from
foreign currency and the West Coast port disruption. Leading our
quarterly performance was our Healthcare/Home Environment segment
driven by new product introductions, a relatively strong end to the
flu season and the VapoSteam acquisition notwithstanding a
significant foreign currency headwind. The Healthy Directions
acquisition contributed almost $40 million to sales revenue.
Housewares had a slight decline in the quarter, as strong
point-of-sale activity and new product introductions were offset by
a shift in timing of customer orders and inventory levels at
several key retailers. In Beauty, we reorganized and renamed the
segment formerly known as Personal Care. While Beauty sales were
down year-over-year, we made continued progress toward stability.
We remain highly focused on executing our multi-year growth
strategy and believe we are on track to achieve the objectives we
have set for ourselves for the current fiscal year.”
Key Highlights for the First Quarter of
Fiscal Year 2016 Compared to the First Quarter of Fiscal Year
2015
- Net sales revenue increased $33.6
million, or 10.8%, which includes a 2.1% decrease in core business
net sales revenue (excluding Nutritional Supplements and
VapoSteam). The decrease in core business net sales revenue
includes a negative impact of 2.5% from foreign currency
fluctuations.
- Healthcare/Home Environment rose 0.4%,
driven by new product introductions, a relatively strong end to the
cold/flu season and the VapoSteam acquisition, primarily offset by
a negative impact of $5.2 million, or 3.6% from foreign currency
fluctuations.
- Housewares declined $1.6 million, or
2.4%, primarily due to a shift in the timing of customer orders of
an estimated $3.0 million into the fourth quarter of fiscal year
2015 and an estimated $1.0 million into the second quarter of
fiscal year 2016, and inventory adjustments by several key
retailers. The decline was partially offset by strong point-of-sale
activity, continued growth with existing products, such as the
infant and toddler care line, and new products, including the
GreenSaver storage containers.
- Beauty declined 4.7%, which included a
negative impact of $2.2 million, or 2.1% from foreign currency
fluctuations. The West Coast port disruption also negatively
impacted net sales revenue.
- Healthy Directions, which comprises the
Nutritional Supplements segment, contributed $39.4 million to net
sales revenue.
- VapoSteam contributed $0.7 million to
net sales revenue.
- Gross margin expanded 3.2 percentage
points to 41.5% due primarily to the Healthy Directions
acquisition.
- Foreign currency exchange losses from
balance sheet re-measurement, transactions and hedge settlements
increased SG&A expense by $0.9 million compared to the same
period last year.
- Diluted EPS was $0.70 and adjusted
diluted EPS was $1.06 on 29.1 million shares outstanding.
- Adjusted EBITDA increased $0.2 million
to $42.1 million.
First Quarter of Fiscal Year 2016
Consolidated Operating Results
- Net sales revenue increased 10.8% to
$345.3 million compared to $311.8 million in the first quarter of
fiscal year 2015, and includes three months of operations of
Healthy Directions, which was acquired on June 30, 2014 and two
months of operations of the VapoSteam business, which was acquired
on March 31, 2015. Net sales revenue reflects a decline in core
business net sales revenue of $6.5 million, or 2.1%. Foreign
currency fluctuations decreased consolidated U.S. Dollar reported
net sales revenue by $7.7 million, or 2.5%, year-over-year.
Additionally, the impact of the West Coast port disruption
negatively impacted net sales revenue, primarily in the Beauty
segment.
- Gross profit margin increased 3.2
percentage points to 41.5% compared to 38.3% for the same period
last year. This increase reflects the impact of the Nutritional
Supplements segment and the recent acquisition of VapoSteam, which
had a combined favorable impact of 4.0 percentage points on the
consolidated gross profit margin. Gross profit margin for the core
business declined by 0.8 percentage points primarily due to the
unfavorable impact of foreign currency fluctuations.
- SG&A was 32.9% of net sales
compared to 28.0% of net sales for the same period last year. The
increase is primarily due to a higher relative SG&A ratio in
the Nutritional Supplements segment, which increased the SG&A
ratio by 4.2 percentage points. The SG&A ratio in the core
business increased 0.8 percentage points, primarily due to higher
year-over-year net foreign currency exchange losses of $0.9
million, as well as higher compensation expense and investments in
advertising, marketing and product development.
- Operating income was $26.5 million
compared to $23.1 million for the same period last year. Operating
income for the fiscal quarter ended May 31, 2015 includes non-cash
asset impairment charges of $3.0 million, compared to $9.0 million
for the same period last year.
- Income tax expense as a percentage of
pretax income was 14.2% compared to 17.0% for the same period last
year. The year-over-year comparison of our effective tax rate was
primarily impacted by shifts in the mix of taxable income in our
various tax jurisdictions.
- Net income was $20.4 million, or $0.70
per diluted share on 29.1 million weighted average diluted shares
outstanding. This compares to net income in the first quarter of
fiscal year 2015 of $16.4 million, or $0.55 per diluted share on
29.6 million weighted average diluted shares outstanding. Net
income for the fiscal quarter ended May 31, 2015 includes after-tax
non-cash asset impairment charges of $2.7 million, compared to $8.2
million for the same period last year.
- Adjusted EBITDA (EBITDA excluding
non-cash asset impairment charges and non-cash share-based
compensation, as applicable) was $42.1 million compared to $41.9
million in the same period last year.
On an adjusted basis for the first quarter of fiscal years 2016
and 2015, excluding non-cash asset impairment charges, non-cash
amortization of intangible assets, and non‐cash share based
compensation, as applicable:
- Adjusted operating income was $38.4
million compared to $38.7 million for the first quarter of fiscal
year 2015.
- Adjusted income was $30.7 million, or
$1.06 per diluted share, compared to $30.8 million, or $1.04 per
diluted share, for the first quarter of fiscal year 2015.
Balance Sheet Highlights
- Cash and cash equivalents totaled $15.3
million at May 31, 2015, compared to $29.2 million at May 31,
2014.
- Total short- and long-term debt
increased to $438.8 million at May 31, 2015, compared to $425.7
million at May 31, 2014. The increase primarily reflects borrowings
incurred in conjunction with the acquisition of Healthy Directions
for $195.9 million in the second quarter of fiscal year 2015, and
the VapoSteam transactions that totaled $42.8 million in the first
quarter of fiscal year 2016.
- Accounts receivable turnover was 57.1
days at May 31, 2015, compared to 63.2 days at May 31, 2014.
- Inventory was $299.3 million at May 31,
2015, compared to $298.5 million at May 31, 2014.
Recent Events
On March 31, 2015, the Company announced that it had acquired
the Vicks® VapoSteam® U.S. liquid inhalant business from The
Procter & Gamble Company (“P&G”), which includes a fully
paid-up license to the Vicks VapoSteam trademarks. In a related
transaction, the Company also acquired a fully paid-up license of
P&G’s Vicks VapoPad® trademarks for scent pads in the United
States. The vast majority of Vicks VapoSteam and VapoPads are used
in Vicks humidifiers, vaporizers and other health care devices
already marketed by Helen of Troy. The transaction includes the
acquisition of certain production assets and the inventory related
to the above categories, as well as the right to use related
intellectual property. The VapoSteam acquisition was financed with
the Company’s revolving credit facility. The United States Vicks
VapoSteam business that was part of the transaction had annual
revenues of approximately $10 million in calendar year 2014. The
aggregate consideration for the two transactions was approximately
$42.8 million.
Early in March 2015, the Company announced the introduction of a
premium line of kitchen electrics under the OXO On brand. The
initial line will consist of motorized toasters, coffee makers, a
coffee grinder, an electric kettle, an immersion blender and a hand
mixer. The line will ship initially in the U.S. offering several
unique features, as well as elements based on OXO’s universal
design ethos. The Company believes OXO On appliances will provide
the simplicity, functionality, and thoughtfulness consumers have
come to expect from the OXO brand. The line is expected to ship to
retail stores in the second half of fiscal year 2016.
Fiscal Year 2016 Annual
Outlook
The Company is maintaining its fiscal year 2016 outlook. For
fiscal year 2016, the Company continues to expect consolidated net
sales revenue in the range of $1.485 to $1.536 billion and diluted
EPS (GAAP) in the range of $4.33 to $4.73. This includes expected
sales and diluted EPS from VapoSteam. The Company continues to
expect sales and diluted EPS (GAAP) from the VapoSteam acquisition
to be in the range of $10 million to $11 million and $0.03 to
$0.08, respectively, for the eleven months included in our fiscal
year 2016 results.
The Company continues to expect consolidated adjusted diluted
EPS (non-GAAP) to be in the range of $5.40 to $5.85, which excludes
after-tax non-cash asset impairment charges, non-cash share-based
compensation expense and intangible asset amortization expense.
This includes expected sales and adjusted diluted EPS from
VapoSteam. The Company continues to expect adjusted diluted EPS
(non-GAAP) for VapoSteam to be in the range of $0.04 to $0.11,
which excludes after-tax non-cash share-based compensation expense
and intangible asset amortization expense.
The Company’s fiscal year 2016 outlook assumes current foreign
currency exchange rates for the remainder of the fiscal year, which
are expected to negatively impact year-over-year net sales revenue
by approximately $28.0 million, net income by approximately $17.0
million, and earnings per share by approximately $0.59. The diluted
EPS outlook is based on an estimated weighted average shares
outstanding of 29.0 million for the full fiscal year 2016. Further,
the Company’s guidance assumes that the severity of the cold/flu
season will be in line with historical averages. The likelihood and
potential impact of any fiscal year 2016 acquisitions other than
VapoSteam, future asset impairment charges, future foreign currency
fluctuations, including any potential currency devaluation in
Venezuela, or share repurchases are unknown and cannot be
reasonably estimated; therefore they are not included in the
Company’s sales and earnings outlook.
As previously disclosed, in fiscal year 2015 the Company
benefitted from an after-tax gain of $0.24 per share from the
amendment of a license agreement, an after-tax decrease in product
liability estimates of $0.05 per share and tax benefits of $0.15
per share that are not expected to repeat in fiscal year 2016.
These items negatively impact the year-over-year comparison of
adjusted diluted EPS by a combined $0.44.
Conference Call and
Webcast
The Company will conduct a teleconference in conjunction with
today's earnings release. The teleconference begins at 4:45 pm
Eastern Time today, Thursday, July 9, 2015. Institutional investors
and analysts interested in participating in the call are invited to
dial (888) 329-8877 approximately ten minutes prior to the start of
the call. The conference call will also be webcast live at:
www.hotus.com. A telephone replay of this call will be available at
7:45 p.m. Eastern Time on July 9, 2015 until 11:59 p.m. Eastern
Time on July 16, 2015 and can be accessed by dialing (877) 870-5176
and entering replay pin number 8777201. A replay of the webcast
will remain available on the website for 60 days.
Non-GAAP Financial
Measures:
The Company reports and discusses its operating results using
financial measures consistent with accounting principles generally
accepted in the United States of America (“GAAP”). To supplement
its presentation, the Company discloses certain financial measures
that may be considered non-GAAP financial measures, such as
adjusted operating income, adjusted income, adjusted diluted EPS,
EBITDA and adjusted EBITDA, which are presented in accompanying
tables to this press release along with a reconciliation of these
financial measures to their corresponding GAAP-based measures
presented in the Company’s consolidated statements of income.
About Helen of Troy
Limited:
Helen of Troy Limited is a leading global consumer products
company offering creative solutions for its customers through a
strong portfolio of well-recognized and widely-trusted brands,
including: Housewares: OXO®, Good Grips®, Soft Works®, OXO tot® and
OXO Steel®; Healthcare/Home Environment: Vicks®, Braun®,
Honeywell®, PUR®, Febreze®, Stinger®, Duracraft® and SoftHeat®; and
Beauty: Revlon®, Vidal Sassoon®, Dr. Scholl's®, Pro Beauty Tools®,
Sure®, Pert®, Infusium23®, Brut®, Ammens®, Hot Tools®, Bed Head®,
Karina®, Ogilvie® and Gold 'N Hot®. The Nutritional Supplements
segment was formed with the acquisition of Healthy Directions, a
U.S. market leader in premium doctor-branded vitamins, minerals and
supplements, as well as other health products sold directly to
consumers. The Honeywell® trademark is used under license from
Honeywell International Inc. The Vicks®, Braun®, Febreze® and Vidal
Sassoon® trademarks are used under license from The Procter &
Gamble Company. The Revlon® trademark is used under license from
Revlon Consumer Products Corporation. The Bed Head® trademark is
used under license from Unilever PLC. The Dr. Scholl's® trademark
is used under license from MSD Consumer Care, Inc.
For more information about Helen of Troy, please visit
www.hotus.com.
Forward Looking
Statements:
This press release may contain forward-looking statements, which
are subject to change. The forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Any or all of the forward-looking
statements may turn out to be wrong. They can be affected by
inaccurate assumptions or by known or unknown risks and
uncertainties. Many of these factors will be important in
determining the Company's actual future results. Consequently, no
forward-looking statement can be guaranteed. Actual future results
may vary materially from those expressed or implied in any
forward-looking statements. The forward-looking statements are
qualified in their entirety by a number of risks that could cause
actual results to differ materially from historical or anticipated
results. Generally, the words "anticipates", "estimates",
"believes", "expects", "plans", "may", "will", "should", "seeks",
"project", "predict", "potential", "continue", "intends", and other
similar words identify forward-looking statements. The Company
cautions readers not to place undue reliance on forward-looking
statements. The Company intends its forward-looking statements to
speak only as of the time of such statements, and does not
undertake to update or revise them as more information becomes
available. The forward-looking statements contained in this press
release should be read in conjunction with, and are subject to and
qualified by, the risks described in the Company's Form 10-K for
the year ended February 28, 2015 and in our other filings with the
SEC. Investors are urged to refer to the risk factors referred to
above for a description of these risks. Such risks include, among
others, the departure and recruitment of key personnel, the
Company's ability to deliver products to our customers in a timely
manner, the costs of complying with the business demands and
requirements of large sophisticated customers, the Company's
relationship with key customers and licensors, our dependence on
the strength of retail economies and vulnerabilities to an economic
downturn, expectations regarding acquisitions and the integration
of acquired businesses, exchange rate risks, disruptions in U.S.,
European and other international credit markets, risks associated
with weather conditions, the Company’s dependence on foreign
sources of supply and foreign manufacturing, risks associated with
the availability, purity and integrity of materials used in
nutritional supplements, the impact of changing costs of raw
materials and energy on cost of goods sold and certain operating
expenses, the Company's geographic concentration of certain U.S.
distribution facilities, which increases our exposure to
significant shipping disruptions and added shipping and storage
costs, the Company's projections of product demand, sales, net
income and earnings per share are highly subjective and our future
net sales revenue and net income could vary in a material amount
from such projections, circumstances that may contribute to future
impairment of goodwill, intangible or other long-lived assets, the
risks associated with the use of trademarks licensed from and to
third parties, the Company's ability to develop and introduce
innovative new products to meet changing consumer preferences,
increased product liability and reputational risks associated with
the formulation and distribution of nutritional supplements, risks
associated with adverse publicity and negative public perception
regarding the use of nutritional supplements, trade barriers,
exchange controls, expropriations, and other risks associated with
foreign operations, the Company’s debt leverage and the constraints
it may impose, the costs, complexity and challenges of upgrading
and managing our global information systems, the risks associated
with information security breaches, the increased complexity of
compliance with a number of new government regulations as a result
of adding nutritional supplements to the Company’s portfolio of
products, the risks associated with tax audits and related disputes
with taxing authorities, potential changes in laws, including tax
laws, and the Company's ability to continue to avoid classification
as a controlled foreign corporation.
HELEN OF TROY LIMITED AND SUBSIDIARIES
Consolidated Condensed Statements of
Income and Reconciliation of Non-GAAP Financial Measures - Adjusted
Operating Income,
Adjusted Income and Adjusted Diluted
Earnings per Share ("EPS")
(Unaudited) (in thousands, except per share data)
Three Months ended May 31,
2015 2014
As Reported (GAAP)
Adjustments (1)
Adjusted(non-GAAP) (1)
As Reported (GAAP)
Adjustments (1)
Adjusted(non-GAAP) (1)
Sales revenue, net $ 345,345
100.0 % $ - $ 345,345
100.0 % $ 311,778 100.0 % $ - $
311,778 100.0 % Cost of goods sold
202,026 58.5 % -
202,026
58.5 % 192,258 61.7
% - 192,258
61.7 %
Gross profit
143,319 41.5 % - 143,319 41.5 % 119,520 38.3 % - 119,520 38.3 %
Selling, general, and administrative expense 113,776 32.9 %
- 104,901 30.4 % 87,397 28.0 % - 80,843 25.9 % (2,061 ) (2 ) (1,295
) (2 ) (6,814 ) (3 ) (5,259 ) (3 ) - - Asset impairment charges
3,000 0.9 % (3,000
) (4 ) - -
% 9,000 2.9 %
(9,000 ) (4 ) - -
% Operating income 26,543 7.7
% 11,875 38,418
11.1 % 23,123
7.4 % 15,554
38,677 12.4 %
Nonoperating income, net 138 - % - 138 - % 50 - % - 50 - % Interest
expense (2,892 ) (0.8 ) % -
(2,892 ) (0.8 ) %
(3,417 ) (1.1 ) % -
(3,417
)
(1.1 ) % Total other expense
(2,754 ) (0.8 ) % -
(2,754 ) (0.8 ) % (3,367
) (1.1 ) % -
(3,367
)
(1.1 ) % Income before income taxes 23,789 6.9
% 11,875 35,664 10.3 % 19,756 6.3 % 15,554 35,310 11.3 %
Income tax expense 3,379 1.0
% 1,583 (5 ) 4,962
1.4 % 3,358
1.1 % 1,189 (5 ) 4,547
1.5 % Net income $ 20,410
5.9 % $ 10,292 $ 30,702
8.9 % $ 16,398
5.3 % $ 14,365 $ 30,763
9.9 % Diluted EPS $ 0.70
$ 0.36 $ 1.06 $ 0.55 $ 0.49 $ 1.04 Weighted average shares
of common stock used in computing diluted EPS 29,088 - 29,088
29,616 - 29,616
HELEN OF TROY LIMITED AND
SUBSIDIARIES Net Sales Revenue by Segment
(Unaudited) (in thousands)
Three Months Ended May 31,
% of Sales Revenue, net 2015 (6
) 2014 $ Change
% Change 2015 2014
Sales revenue by segment, net
Housewares $ 65,186 $ 66,756 $ (1,570 ) (2.4 ) % 18.9 % 21.4 %
Healthcare / Home Environment 143,042 142,489 553 0.4 % 41.4 % 45.7
% Nutritional Supplements 39,440 - 39,440 * 11.4 % - % Beauty
97,677 102,533
(4,856 ) (4.7 ) % 28.3 % 32.9 %
Total sales revenue, net $ 345,345 $ 311,778 $
33,567 10.8 %
100.0 % 100.0 %
* Calculation is not meaningful
HELEN OF TROY LIMITED AND
SUBSIDIARIES Selected Consolidated Balance Sheet,
Cash Flow and Liquidity Information (Unaudited) (in
thousands) May 31,
2015 2014 Balance Sheet:
Cash and cash equivalents $ 15,262 $ 29,170
Receivables, net 210,001 217,415 Inventory, net 299,300 298,450
Total assets, current 565,743 586,294 Total assets 1,687,138
1,487,655 Total liabilities, current 268,442 541,471 Total
long-term liabilities 486,559 166,381 Total debt 438,807 425,707
Stockholders' equity 932,137 779,803 Cash Flow: Depreciation
and amortization $ 10,354 $ 8,500 Net cash provided by operating
activities 37,499 2,971 Capital and intangible asset expenditures
2,717 1,822 Payments to acquire businesses, net of cash received
42,750 - Net amounts borrowed 5,600 233,100 Liquidity:
Working Capital $ 297,301 $ 44,823 Leverage Ratio (8) 1.97 2.22
SELECTED OTHER DATA
Reconciliation of Non-GAAP Financial
Measures - EBITDA (Earnings Before Interest, Taxes, Depreciation
and Amortization) and
Adjusted EBITDA (Unaudited) (in thousands)
Three Months Ended May
31, 2015 2014
Net income $ 20,410 $ 16,398 Interest expense, net 2,874
3,396 Income tax expense 3,379 3,358 Depreciation and
amortization, excluding amortized interest 10,354
8,500 EBITDA (Earnings before interest, taxes,
depreciation and amortization) (1) $ 37,017 $ 31,652
Adjusted EBITDA: EBITDA, as calculated above (1) $
37,017 $ 31,652 Non-cash share-based compensation (2) 2,061
1,295 Non-cash asset impairment charges (4)
3,000 9,000 Adjusted EBITDA (1) $
42,078 $ 41,947
SELECTED OTHER DATA
Reconciliation of Non-GAAP Financial
Measures - EBITDA (Earnings Before Interest, Taxes, Depreciation
and Amortization) and
Adjusted EBITDA by Segment (Unaudited) (in
thousands) Three
Months Ended May 31, 2015 Housewares
Healthcare
/HomeEnvironment
NutritionalSupplements
Beauty
Total Operating
Income $ 11,183 $ 8,418 $ 2,620 $ 4,322 $ 26,543
Depreciation and amortization, excluding amortized interest 1,008
5,063 1,968 2,315 10,354 Other income / (expense)
- - - 120
120 EBITDA (Earnings before interest, taxes,
depreciation and amortization) (1) $ 12,191 $ 13,481
$ 4,588 $ 6,757 $ 37,017
Adjusted EBITDA: EBITDA, as calculated above (1) $ 12,191 $
13,481 $ 4,588 $ 6,757 $ 37,017 Non-cash share-based
compensation (2) 306 595 303 857 2,061 Non-cash asset
impairment charges (4) - - -
3,000 3,000
Adjusted EBITDA (1) $ 12,497 $ 14,076 $ 4,891 $
10,614 $ 42,078
Three
Months Ended May 31, 2014 Housewares
Healthcare
/HomeEnvironment
NutritionalSupplements
Beauty Total Operating Income $ 13,035 $ 8,717
$ - $ 1,371 $ 23,123 Depreciation and amortization,
excluding amortized interest 888 5,232 - 2,380 8,500 Other
income / (expense) - - -
29 29 EBITDA (Earnings
before interest, taxes, depreciation and amortization) (1) $
13,923 $ 13,949 $ - $ 3,780 $
31,652 Adjusted EBITDA: EBITDA, as calculated above
(1) $ 13,923 $ 13,949 $ - $ 3,780 $ 31,652 Non-cash
share-based compensation (2) 274 581 - 440 1,295 Non-cash
asset impairment charges (4) - -
- 9,000 9,000
Adjusted EBITDA (1) $ 14,197 $ 14,530 $ - $
13,220 $ 41,947
HELEN OF TROY
LIMITED AND SUBSIDIARIES
Reconciliation of GAAP Net Income and
Earnings Per Share (EPS) to Adjusted Income and Adjusted EPS
(non-GAAP)
(dollars in thousands, except per share data)
(Unaudited) Three
Months Ended May 31, Basic EPS
Diluted EPS 2015
2014 2015 2014
2015 2014
Net income as
reported (GAAP) $ 20,410 $ 16,398 $ 0.72 $ 0.56 $ 0.70 $ 0.55 Asset
impairment charges, net of tax (4) 2,656
8,155 0.09 0.28
0.09 0.28 Subtotal
23,066 24,553 0.81
0.84 0.79
0.83 Non-cash share-based compensation, net of tax (2) 1,742 1,168
0.06 0.04 0.06 0.04 Amortization of intangible assets, net of tax
(3) 5,894 5,042
0.21 0.17 0.20
0.17 Adjusted income (non-GAAP) (1) $ 30,702 $
30,763 $ 1.08 $ 1.06 $
1.06 $ 1.04 Weighted average shares of
common stock used in computing basic and diluted earnings per share
(non-GAAP) 28,520 29,105 29,088 29,616
HELEN OF
TROY LIMITED AND SUBSIDIARIES
Reconciliation of Fiscal Year 2016 GAAP
Outlook for GAAP Diluted Earnings Per Share (EPS) to Adjusted
Diluted EPS (non-GAAP)
(Unaudited) Fiscal
Year Ended February 29, 2016 (7)
Quarter EndedMay 31,
2015(Three Months)
Outlook for theBalance of
theFiscal Year(Nine Months)
Outlook for theFiscal
Year(Twelve Months)
Diluted EPS, as reported (GAAP) $ 0.70 $ 3.54
- $ 3.94 4.24 - $ 4.64 Asset impairment
charges, net of tax (4) 0.09 - -
- 0.09 - 0.09 Subtotal
0.79 3.54 - 3.94 4.33 - 4.73 Non-cash share-based compensation, net
of tax (2) 0.06 0.19 - 0.22 0.25 - 0.28 Amortization of intangible
assets, net of tax (3) 0.20 0.62
- 0.64 0.82 - 0.84
Adjusted diluted EPS (non-GAAP) (1) $ 1.06 $ 4.34
- $ 4.79 $ 5.40 - $ 5.85
HELEN OF TROY LIMITED AND
SUBSIDIARIES
_____________________
Notes to Press Release
(1) This press release contains non-GAAP financial
measures. Adjusted operating income, adjusted income, adjusted
diluted EPS, EBITDA and adjusted EBITDA (“Non-GAAP measures”) that
are discussed in the accompanying press release or in the preceding
tables are considered non-GAAP financial information as
contemplated by SEC Regulation G, Rule 100. Accordingly, we are
providing the preceding tables that reconcile these measures to
their corresponding GAAP-based measures presented in our
Consolidated Condensed Statements of Income in the accompanying
tables to the press release. The Company believes that these
non-GAAP measures provide useful information to management and
investors regarding financial and business trends relating to its
financial condition and results of operations. The Company believes
that these non-GAAP measures, in combination with the Company's
financial results calculated in accordance with GAAP, provides
investors with additional perspective. The Company further believes
that the items excluded from certain non-GAAP measures do not
accurately reflect the underlying performance of its continuing
operations for the periods in which they are incurred, even though
some of these excluded items may be incurred and reflected in the
Company's GAAP financial results in the foreseeable future. The
material limitation associated with the use of the non-GAAP
financial measures is that the non-GAAP measures do not reflect the
full economic impact of the Company's activities. These non-GAAP
measures are not prepared in accordance with GAAP, are not an
alternative to GAAP financial information, and may be calculated
differently than non-GAAP financial information disclosed by other
companies. Accordingly, undue reliance should not be placed on
non-GAAP information. (2) Adjustments consist of non-cash
share-based compensation expense of $2.06 million ($1.74 million
after tax) and $1.30 million ($1.17 million after tax), for the
three months ended May 31, 2015 and 2014, respectively. Share-based
compensation expense is recognized for share-based awards
outstanding under share-based compensation plans. (3)
Adjustments consist of non-cash intangible asset amortization
expense of $6.81 million ($5.89 million after tax) and $5.26
million ($5.04 million after tax), respectively, for the three
months ended May 31, 2015 and 2014, respectively. (4)
Adjustments consist of non-cash asset impairment charges of $3.00
million ($2.66 million after tax) and $9.00 million ($8.16 million
after tax) recorded during the three months ended May 31, 2015 and
2014, respectively, as a result of our annual evaluation of
goodwill and indefinite-lived intangible assets for impairment. The
non-cash charges relate to certain trademarks in our Beauty
segment, which were written down to their estimated fair value,
determined on the basis of future discounted cash flows using the
relief from royalty valuation method. (5) Total tax effects
of adjustments described in Notes 2 through 4, for each of the
periods presented:
Three Months
Ended May 31, 2015
2014
Tax Effects of
Adjustments
Non-cash share-based compensation (2) $
(319) $ (127) Amortization of intangible assets (3) (920) (217)
Asset impairment charges (4) (344)
(845) Total $ (1,583) $
(1,189) (6) Includes three months of operations of
Healthy Directions, which was acquired on June 30, 2014, and two
months of operations of the VapoSteam business, which was acquired
on March 31, 2015. (7)
The diluted EPS outlook is based on an
estimated weighted average shares outstanding of 29.00 million for
fiscal year 2016.
(8)
The leverage ratio is computed as defined
in the Company’s revolving credit agreement, which is as
follows:
Funded Indebtedness (a)
________________________________________________________________________
EBITDA (b) + Pro Forma Effect of Acquisitions (c) (a) Funded
Indebtedness: total debt plus the total letters of credit
outstanding at the end of the reporting period. (b) EBITDA:
earnings before non-cash charges, interest expense, taxes,
depreciation and amortization expense, and share-based compensation
for the latest reported four consecutive fiscal quarters.
(c) Pro Forma Effect of Acquisitions: for any acquisition,
pre-acquisition EBITDA of the acquired business so that EBITDA of
the acquired business includes the latest twelve month trailing
total.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150709006205/en/
Investors:ICR, Inc.Allison Malkin / Anne Rakunas203-682-8200 /
310-954-1100
Helen of Troy (NASDAQ:HELE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Helen of Troy (NASDAQ:HELE)
Historical Stock Chart
From Apr 2023 to Apr 2024